XACDURO (COPACKAGED)
Peaksulbactam and durlobactam
NDAINTRAVENOUSPOWDERPriority Review
Approved
May 2023
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 5h ago · AI intelligence enriched 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XACDURO is a copackaged intravenous powder combination of sulbactam and durlobactam, a novel beta-lactamase inhibitor-beta-lactam antibiotic combination for treating serious bacterial infections. Durlobactam is a next-generation beta-lactamase inhibitor designed to overcome resistance mechanisms that limit older inhibitors like sulbactam. The drug targets patients with multidrug-resistant gram-negative infections where standard therapies have failed.
Peak9.1 years to LOE
Early peak lifecycle with strong patent protection suggests opportunity to build brand awareness and capture specialist infectious disease market share before LOE.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
XACDURO offers career opportunity in a high-stakes specialty infectious disease niche with differentiated mechanism and strong patent runway. Professionals joining now enter a growth-stage product with 9+ years of exclusivity, positioning for expanded indication development and hospital formulary penetration.
Brand ManagerMedical Science Liaison (Infectious Disease)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.